Aclarion, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ACON, updated each market day.
ACON AI Sentiment
AI sees no strong directional signal for Aclarion, Inc. Common Stock stock over the next 10 market days.
Prediction date: July 2, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Aclarion, Inc. Common Stock
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Sector
Exchange
Market Cap
$6,672,697
Cap Tier
Employees
11
Headquarters
BROOMFIELD, CO
Listed Since
April 22, 2022
Website
ACON Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ACON Volatility
Aclarion, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
